IP Library Granted Patent US 7,585,957
Granted Patent B2
US 7,585,957 · App. 11/197,219 · Granted Sep 8, 2009

Site specific system for generating diversity protein sequences

Assignees: The Regents of the University of California; AvidBiotics Corp
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,585,957
App. No.
11/197,219
Granted
Sep 8, 2009
Kind
B2
Abstract

This invention relates to the diversification of nucleic acid sequences by use of a nucleic acid molecule containing a region of sequence that acts as a template for diversification. The invention thus provides nucleic acid molecules to be diversified, as well as those which act as the template region (TR) and in concert with the TR for directional, site-specific diversification. Further provided are methods of preparing and using these nucleic acid sequences.

Claims (12)

1. A single recombinant nucleic acid molecule or pair of recombinant nucleic acid molecules comprising

a variable region (VR) operably linked to a donor template region (TR)

wherein said TR comprises an imperfect repeat of the sequence in said VR due to the substitution of non-adenine nucleotides in VR at positions corresponding to one or more adenine nucleotides in TR and said TR is operably linked to a reverse transcriptase (RT) coding sequence which said RT directs at sites of adenine in said TR site-specific mutagenesis of said VR, and

wherein the TR and RT coding sequence are heterologous to each other.

2. The molecule of claim 1 , wherein said VR is all or part of a sequence encoding a specific binding partner of a target molecule.

3. The molecule of claim 2 , further comprising all of the sequence encoding said binding partner, wherein said VR is optionally the 3′ portion of said sequence encoding said binding partner.

4. The molecule of claim 2 , wherein said binding partner binds a cell surface molecule, a hormone, a growth or differentiation factor, a receptor, a ligand of a receptor, a bacterial cell wall molecule, a viral particle, an immunity or immune tolerance factor, or an MHC molecule.

5. The molecule of claim 2 , wherein said binding partner is a bacteriocin.

6. The molecule or pair of molecules of claim 1 , wherein said TR and RT coding sequences are transcribed under the control of a heterologous promoter, such as the fha promoter.

7. A cell containing the molecule or pair of molecules of claim 1 .

8. A plurality or library of nucleic acid molecules according to claim 1 .

9. The plurality or library of claim 8 , wherein the VR has undergone diversification directed by the TR.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jul 16, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024700/0921 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Oct 27, 2008
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021743/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2006
From: MILLER, JEFFREY F.; DOULATOV, SERGEI; HODES, ASHER; XU, MIN; GINGERY, MARI
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 017227/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2006
From: MARTIN, DAVID W.
To: AVIDBIOTICS CORP
Reel/Frame 017231/0442 →
Continuity (2)
Provisional Application 6059861700 · Aug 3, 2004
Related Publication 20060121450A1 · Jun 8, 2006